Efficacy of an anti-CD5-ricin a chain immunoconjugate in an improved human peripheral blood lymphocyte-reconstituted severe combined immunodeficient mouse model
- 31 August 1993
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 15 (6) , 695-709
- https://doi.org/10.1016/0192-0561(93)90142-l
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Treatment of lupus nephritis with cd5 plus, an immunoconjugate of an anti‐cd5 monoclonal antibody and ricin a chainArthritis & Rheumatism, 1992
- Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood.The Journal of Experimental Medicine, 1992
- Cytotoxicity against human peripheral blood mononuclear cells and T cell lines mediated by anti-T cell immunotoxins in the absence of added potentiatorClinical and Experimental Immunology, 1991
- Substituted 2-iminothiolanes: reagents for the preparation of disulfide cross-linked conjugates with increased stabilityBioconjugate Chemistry, 1990
- Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice.The Journal of Experimental Medicine, 1989
- On the SCIDs?Nature, 1989
- The SCID-hu Mouse: Murine Model for the Analysis of Human Hematolymphoid Differentiation and FunctionScience, 1988
- Transfer of a functional human immune system to mice with severe combined immunodeficiencyNature, 1988
- Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies.The Journal of Experimental Medicine, 1985
- Higher cytolytic efficiency of an IgG2α than of an IgG1 monoclonal antibody reacting with the same (or spatially close) determinant on a human high-molecular-weight melanoma-associated antigenCellular Immunology, 1982